MEDVi vs Zealthy: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Zealthy overall, scoring 7.7/10 vs 7.2/10. Zealthy is more affordable at $286/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Zealthy for users who want the option to switch between compounded and b.
A side-by-side comparison of MEDVi and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViZealthy
#35 of 40Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.
Visit Zealthy| Feature | MEDVi | Zealthy |
|---|---|---|
| Our Score | 7.7/10 | 7.2/10 |
| Starting Price | $299/mo | $286/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want the option to switch between compounded and brand-name GLP-1s |
| Ranking | #21 | #35 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Zealthy
Pros
- +Dedicated insurance coordinators handle prior authorizations — potentially bringing brand-name GLP-1 costs to $25/mo
- +Multi-month supply options (3, 6, or 12 months) — unique convenience most monthly-shipping competitors can't match
- +Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
- +LegitScript certified with 4.5-star Review.io rating
Cons
- −$135 membership fee on top of medication cost makes cash-pay total ~$286/mo for semaglutide — above average
- −Young company (founded 2023) with a relatively small review base — less track record than established platforms
- −Prescription products are non-refundable for any reason once ordered
Our Verdict
MEDVi edges out Zealthy with a score of 7.7/10 vs 7.2/10. If budget is your priority, Zealthy starts at $286/mo compared to MEDVi's $299/mo. Zealthy offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.